Evidence map›Paper›PMID 36141609›Full record

ArticleInternational journal of environmental research and public health2022

Radon Progeny Adsorption on Facial Masks.

Annika Hinrichs, Claudia Fournier, Gerhard Kraft, Andreas Maier

Open access · goldAbstract read
In one paragraph

Article in International journal of environmental research and public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
1.4field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 8 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Annika HinrichsGSI Helmholtzzentrum Für Schwerionenforschung GmbH, Planckstr. 1, 64291 Darmstadt, Germany.
Claudia FournierGSI Helmholtzzentrum Für Schwerionenforschung GmbH, Planckstr. 1, 64291 Darmstadt, Germany.
Gerhard KraftGSI Helmholtzzentrum Für Schwerionenforschung GmbH, Planckstr. 1, 64291 Darmstadt, Germany.
Andreas MaierGSI Helmholtzzentrum Für Schwerionenforschung GmbH, Planckstr. 1, 64291 Darmstadt, Germany.ORCID 0000-0003-1309-5435
GSI Helmholtz Centre for Heavy Ion Research · DEGoethe University Frankfurt · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The radioactive noble gas radon and its short-living progeny are inhaled during respiration, depositing their decay energies in the lungs. These progeny are considered responsible for more than 95% of the total effective dose and are, together with radon, classified as carcinogenic for lung cancer. Consequently, filtration of the progeny could reduce the dose to the lungs. In our study, we investigated the filtration properties of FFP2 versus surgical masks (II R) for radon and its decay products. The masks were attached to a measurement device, which enabled determination of the size distribution of radon progeny, ranging from unattached to clustered progeny. In parallel, it measured the radon activity concentration during experiments. By comparing background measurements without mask and experiments with masks, the percentage of retained unattached radon progeny was determined for FFP2 (98.8 ± 0.6%) and II R masks (98.4 ± 0.7%). For clustered progeny, the retained fraction was 85.2 ± 18.1% for FFP2 and 79.5 ± 22.1% for II R masks while radon was not filtered. We can show that masks are effective in filtering radon progeny and thus are capable of reducing the total effective dose to the lungs.

Indexed as

Air Pollutants, RadioactiveAir Pollution, IndoorRadiation MonitoringRadonAdsorptionFiltrationRadon DaughtersAir Pollutants, RadioactiveRadonRadon DaughtersFFP2 masksfiltrationradon progeny

Identifiers

PMID36141609
PMCPMC9517228
OpenAlexW4295213615

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.